165 related articles for article (PubMed ID: 30706675)
1. Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis.
Liu ZL; Liu PP; Bi XW; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2019 Mar; 8(3):874-881. PubMed ID: 30706675
[TBL] [Abstract][Full Text] [Related]
2. Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt Lymphoma.
Xie Y; Jia M; Shi J; Tao Y
Cancer Med; 2020 May; 9(9):3107-3114. PubMed ID: 32160410
[TBL] [Abstract][Full Text] [Related]
3. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Cancer; 2013 Oct; 119(20):3672-9. PubMed ID: 23913575
[TBL] [Abstract][Full Text] [Related]
4. Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases.
Costa LJ; Xavier AC; Wahlquist AE; Hill EG
Blood; 2013 Jun; 121(24):4861-6. PubMed ID: 23641015
[TBL] [Abstract][Full Text] [Related]
5. Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.
Mukhtar F; Boffetta P; Risch HA; Park JY; Bubu OM; Womack L; Tran TV; Zgibor JC; Luu HN
Int J Cancer; 2017 Apr; 140(7):1494-1502. PubMed ID: 28006853
[TBL] [Abstract][Full Text] [Related]
6. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
[TBL] [Abstract][Full Text] [Related]
7. Survival in advanced diffuse large B-cell lymphoma in pre- and post-rituximab Eras in the United States.
Shah BK; Bista A; Shafii B
Anticancer Res; 2014 Sep; 34(9):5117-20. PubMed ID: 25202101
[TBL] [Abstract][Full Text] [Related]
8. Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in Uganda.
McGoldrick SM; Mutyaba I; Adams SV; Larsen A; Krantz EM; Namirembe C; Mooka P; Nabakooza S; Ndagire M; Mubiru K; Nabwana M; Nankinga R; Gerdts S; Gordon-Maclean C; Geriga F; Omoding A; Sessle E; Kambugu J; Uldrick TS; Orem J; Casper C
Pediatr Blood Cancer; 2019 Sep; 66(9):e27813. PubMed ID: 31157502
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and prognosis of children with Burkitt's lymphoma: an analysis of 62 cases].
Wang YC; DU WC; Yin CY; Gong X; Li YF
Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):561-565. PubMed ID: 35644197
[TBL] [Abstract][Full Text] [Related]
10. Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Zhu KY; Song KW; Connors JM; Leitch H; Barnett MJ; Ramadan K; Slack GW; Abou Mourad Y; Forrest DL; Hogge DE; Nantel SH; Narayanan S; Nevill TJ; Power MM; Sanford DS; Sutherland HJ; Tucker T; Toze CL; Sehn LH; Broady R; Gerrie AS
Br J Haematol; 2018 Jun; 181(6):782-790. PubMed ID: 29741758
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
12. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.
Mbulaiteye SM; Anderson WF; Bhatia K; Rosenberg PS; Linet MS; Devesa SS
Int J Cancer; 2010 Apr; 126(7):1732-9. PubMed ID: 19810101
[TBL] [Abstract][Full Text] [Related]
13. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
[TBL] [Abstract][Full Text] [Related]
14. Advanced Burkitt Lymphoma in Sub-Saharan Africa Pediatric Units: Results of the Third Prospective Multicenter Study of the Groupe Franco-Africain d'Oncologie Pédiatrique.
Bouda GC; Traoré F; Couitchere L; Raquin MA; Guedenon KM; Pondy A; Moreira C; Rakotomahefa M; Harif M; Patte C
J Glob Oncol; 2019 Nov; 5():1-9. PubMed ID: 31794283
[TBL] [Abstract][Full Text] [Related]
15. Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
Todeschini G; Bonifacio M; Tecchio C; Balter R; Carli G; Stefani PM; Adami F; Zamò A; Dei Tos AP; Marino F; Gherlinzoni F; Marradi P; Semenzato G; Pizzolo G
Am J Hematol; 2012 Jan; 87(1):22-5. PubMed ID: 22086870
[TBL] [Abstract][Full Text] [Related]
16. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
Sakarou M; Eisele L; Dührsen U; Hüttmann A
Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
[TBL] [Abstract][Full Text] [Related]
19. Role of radiation therapy in primary mediastinal large B-cell lymphoma in rituximab era: A US population-based analysis.
Giri S; Bhatt VR; Pathak R; Bociek RG; Vose JM; Armitage JO
Am J Hematol; 2015 Nov; 90(11):1052-4. PubMed ID: 26270899
[TBL] [Abstract][Full Text] [Related]
20. Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database.
Liu PP; Xia Y; Bi XW; Wang Y; Sun P; Yang H; Li ZM; Jiang WQ
Dis Markers; 2018; 2018():7473935. PubMed ID: 30410635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
